Product image of Medikinet Cr (Methylphenidate Hydrochloride) supplied by GNH India

Medikinet Cr

Active Ingredient:
Methylphenidate Hydrochloride
Origin:
EU

Medikinet Cr (Methylphenidate Hydrochloride)

Methylphenidate, the active ingredient in Medikinet Cr, is a central nervous system stimulant presented as a tablet for oral use. It treats attention deficit hyperactivity disorder (ADHD) and narcolepsy in children, adolescents, and adults.

GNH India supplies Medikinet Cr as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Medice Arzneimittel Pütter Gmbh & Co. Kg

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Methylphenidate is used to manage conditions within the central nervous system stimulant therapeutic area.

  • Attention deficit hyperactivity disorder (ADHD): improves attention, reduces hyperactivity and impulsivity in children, adolescents, and adults.
  • Narcolepsy: decreases excessive daytime sleepiness and improves wakefulness.
  • Attention deficit disorder (ADD): enhances focus and academic performance in individuals with attention difficulties.

How It Works

  • Methylphenidate inhibits the reuptake of dopamine and norepinephrine by blocking their transporters, leading to increased concentrations of these neurotransmitters in the synaptic cleft. The elevated catecholamine levels enhance neuronal signaling in brain regions that regulate attention, impulse control, and wakefulness, producing its therapeutic effects.

Side Effects

Methylphenidate may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

  • Insomnia
  • Loss of appetite
  • Headache
  • Stomach pain
  • Nausea
  • Weight loss

Serious or Rare Side Effects

  • Cardiovascular events (e.g., hypertension, tachycardia)
  • Psychiatric symptoms (e.g., psychosis, mania)
  • Severe allergic reactions (e.g., rash, angioedema)
  • Growth suppression in children
  • Tics or worsening of pre‑existing tics

Precautions & Warnings

When prescribing Methylphenidate, clinicians should consider several safety precautions.

  • Cardiovascular assessment: evaluate heart disease history before initiating therapy.
  • Psychiatric evaluation: monitor for emergence of psychosis, mania, or severe anxiety.
  • Growth monitoring: regularly assess height and weight in pediatric patients.
  • Potential for abuse: assess risk of dependence and misuse.
  • Drug interactions: review concomitant medications for possible interactions.
  • Store at ambient temperature: keep below 25°C, protect from moisture in original packaging.

Avoid Interactions

Methylphenidate can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

  • Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis; avoid concurrent use.
  • Tricyclic antidepressants: may increase cardiovascular side effects.
  • Antihypertensive agents: may reduce blood pressure control.
  • Antipsychotics: may diminish stimulant effect.
  • Severe liver impairment drugs: may alter metabolism.

Moderate Interactions (Monitor Closely)

  • CYP2D6 inhibitors (e.g., fluoxetine): may increase methylphenidate levels.
  • CYP3A4 inducers (e.g., carbamazepine): may reduce effectiveness.
  • Diuretics: may enhance risk of electrolyte imbalance.
  • Antacids: may affect absorption.
  • Alcohol: can increase central nervous system side effects.

Frequently Asked Questions

Medikinet Cr contains methylphenidate, a central nervous system stimulant prescribed primarily for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. It helps improve focus, reduce hyperactivity, and increase wakefulness in patients diagnosed with these conditions.

Methylphenidate blocks the reuptake of dopamine and norepinephrine in the brain, raising their levels at synaptic sites. The increased neurotransmitter activity enhances neuronal signaling in pathways that control attention, impulse regulation, and alertness, which underlies its therapeutic effect.

The appropriate dose of Medikinet Cr is individualized and set by a qualified prescriber based on the patient’s age, weight, severity of symptoms, and response to therapy. Dosing guidelines provide a range, but the final regimen is decided by the treating clinician.

Safety data for methylphenidate in pregnancy and lactation are limited. Prescribers weigh potential benefits against possible risks to the fetus or infant. If treatment is essential, it may be continued under close medical supervision, but alternative therapies are often considered.

To order Medikinet Cr, visit the product page on gnhindia.com, submit an enquiry with the required quantity, and provide your institutional or trade credentials. GNH India’s team will verify eligibility, then respond with pricing, availability, shipping details, and any necessary import documentation.

Medikinet Cr (methylphenidate) is a short‑acting stimulant, whereas other options such as amphetamine‑based products may have longer duration or different side‑effect profiles. Choice of therapy depends on patient response, tolerability, duration of action needed, and clinician preference.

Store Medikinet Cr at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Medikinet Cr is taken orally, usually with water. The tablet should be swallowed whole and not crushed or chewed unless specifically instructed by a healthcare professional. Dosing times are typically scheduled to align with the patient’s daily routine.

Serious risks include cardiovascular events such as hypertension or tachycardia, psychiatric manifestations like psychosis or mania, severe allergic reactions, and potential for dependence or abuse. Patients should be monitored regularly for these adverse outcomes.

Medikinet Cr is contraindicated in individuals with known hypersensitivity to methylphenidate, those taking monoamine oxidase inhibitors, patients with severe cardiovascular disease, uncontrolled hypertension, or a history of psychosis. It should also be avoided in patients with a high risk of substance misuse.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Methylphenidate Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT